Publication Name	World Journal of Gastroenterology
Manuscript ID	91464
Country	Poland

Received	2023-12-28 21:28
Peer-Review Started	2023-12-28 21:28
To Make the First Decision
Return for Revision	2024-03-05 21:02
Revised	2024-04-07 16:41
Second Decision	2024-04-24 02:47
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-04-24 05:18
Articles in Press	2024-04-24 05:18
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-04-29 16:19
Publish the Manuscript Online	2024-05-11 10:58

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration
Manuscript Source	Invited Manuscript
All Author List	Aleksandra Boldys and Lukasz Buldak
Funding Agency and Grant Number
Corresponding Author	Lukasz Buldak, MD, PhD, Associate Professor, Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of Silesia, Medykow 18, Katowice 40-752, Poland. lbuldak@gmail.com
Key Words	Metabolic dysfunction-associated steatotic liver disease; Diagnostics; Pathophysiology of metabolic dysfunction-associated steatotic liver disease; Therapy of metabolic dysfunction-associated steatotic liver disease; Therapeutic innovations
Core Tip	The transition from non-alcoholic fatty liver disease to metabolic dysfunction-associated steatotic liver disease (MASLD) reflects a broader understanding of liver steatosis beyond obesity-related factors. Early recognition and diagnosis of MASLD are essential. Updated diagnostic protocols and exploration of novel therapeutic avenues focusing on metabolic dysregulation are critical for improving outcomes in MASLD management. Cross-disciplinary collaboration is key to addressing the complexities of this disease effectively.
Publish Date	2024-05-11 10:58
Citation	<p>Boldys A, Buldak L. Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration. <i>World J Gastroenterol</i> 2024; 30(18): 2387-2390</p>
URL	https://www.wjgnet.com/1007-9327/full/v30/i18/2387.htm
DOI	https://dx.doi.org/10.3748/wjg.v30.i18.2387

Full Article (PDF)	WJG-30-2387-with-cover.pdf
Manuscript File	91464_Auto_Edited-YJP.docx
Answering Reviewers	91464-Answering reviewers.pdf
Audio Core Tip	91464-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	91464-Conflict-of-interest statement.pdf
Copyright License Agreement	91464-Copyright license agreement.pdf
Peer-review Report	91464-Peer-review(s).pdf
Scientific Misconduct Check	91464-Bing-Liu H-2.png
Scientific Editor Work List	91464-Scientific editor work list.pdf
CrossCheck Report	91464-CrossCheck report.pdf